[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
刘萍. 中国大陆13年宫颈癌临床流行病学大数据评价[J]. 中国实用妇科与产科杂志, 2018, 34(1): 41-45.
|
[3]
|
赵博, 陈红. 宫颈癌癌前病变及宫颈癌筛查方法研究进展[J]. 临床军医杂志, 2020, 48(8): 983-985.
|
[4]
|
Gaffney, D.K., Hashibe, M., Kepka, D., Maurer, K.A. and Werner, T.L. (2018) Too Many Women Are Dying from Cervix Cancer: Problems and Solutions. Gynecologic Oncology, 151, 547-554.
https://doi.org/10.1016/j.ygyno.2018.10.004
|
[5]
|
Crosbie, E.J., Einstein, M.H., Franceschi, S. and Kitchener, H.C. (2013) Human Papillomavirus and Cervical Cancer. The Lancet, 382, 889-899. https://doi.org/10.1016/S0140-6736(13)60022-7
|
[6]
|
Tsu, V. and Jeronimo, J. (2016) Saving the World’s Women from Cervical Cancer. The New England Journal of Medicine, 374, 2509-2511. https://doi.org/10.1056/NEJMp1604113
|
[7]
|
Hausen, H.Z. (2009) Papillomaviruses in the Causation of Human Cancers—A Brief Historical Account. Virology, 384, 260-265. https://doi.org/10.1016/j.virol.2008.11.046
|
[8]
|
Forman, D., Martel, C.D., Lacey, C.J., et al. (2012) Global Burden of Human Papillomavirus and Related Diseases. Vaccine, 30, F12-F23. https://doi.org/10.1016/j.vaccine.2012.07.055
|
[9]
|
Chen, S.S., Block, B.S. and Chan, P.J. (2015) Pentoxifylline Attenuates HPV-16 Associated Necrosis in Placental Trophoblasts. Archives of Gynecology and Obstetrics, 291, 647-652. https://doi.org/10.1007/s00404-014-3471-6
|
[10]
|
Hermonat, P.L., Kechelava, S., Lowery, C.L. and Korourian, S. (1998) Trophoblasts Are the Preferential Target for Human Papilloma Virus Infection in Spontaneously Aborted Products of Conception. Human Pathology, 29, 170-174.
https://doi.org/10.1016/S0046-8177(98)90228-3
|
[11]
|
车雅敏, 王家璧. HPV在宫颈癌发病中的作用机制研究[J]. 国外医学肿瘤学分册, 2004, 31(4): 306-309.
|
[12]
|
Klingelhutz, A.J. and Roman, A. (2012) Cellular Transfor-mation by Human Papillomaviruses: Lessons Learned by Comparing High- and Low-Risk Viruses. Virology, 424, 77-98. https://doi.org/10.1016/j.virol.2011.12.018
|
[13]
|
Hildasheim, A., Herrero, R., Wacholder, S., et al. (2007) Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine among Young Women with Preexisting Infection: A Ran-domized Trial. JAMA, 298, 743-753.
https://doi.org/10.1001/jama.298.7.743
|
[14]
|
Wen, X., Li, D., Zhang, Y., et al. (2012) Arsenic Trioxide Induces Cervical Cancer Apoptosis, But Specifically Targets Human Papillomavirus-Infected Cell Populations. Anti-Cancer Drugs, 23, 280-287.
https://doi.org/10.1097/CAD.0b013e32834f1fd3
|
[15]
|
Alarifi, S., Ali, D., Alkahtani, S., Siddiqui, M. and Ali, B.A. (2013) Arsenic Trioxide-Mediated Oxidative Stress and Genotoxicity in Human Hepatocellular Carcinoma Cells. Onco-Targets and Therapy, 6, 75-84.
https://doi.org/10.2147/OTT.S38227
|
[16]
|
Yu, J., Qian, H., Li, Y., et al. (2007) Therapeutic Effect of Arsenic Tri-oxide (As2O3) on Cervical Cancer in vitro and in vivo through Apoptosis Induction. Cancer Biology & Therapy, 6, 580-586. https://doi.org/10.4161/cbt.6.4.3887
|
[17]
|
Sun, X., Fu, P., Xie, L., et al. (2021) Resveratrol Inhibits the Progression of Cervical Cancer by Suppressing the Transcription and Expression of HPV E6 and E7 Genes. Internation-al Journal of Molecular Medicine, 47, 335-345.
https://doi.org/10.3892/ijmm.2020.4789
|
[18]
|
Liu, Z.G., Zhu, W.H., Kong, X.Y., et al. (2019) Tanshinone IIA In-hibits Glucose Metabolism Leading to Apoptosis in Cervical Cancer. Oncology Reports, 42, 1893-1903. https://doi.org/10.3892/or.2019.7294
|
[19]
|
李桂玲, 归绥琪, 夏晴, 等. 掌叶半夏有效提取物对宫颈癌细胞株增殖的抑制作用[J]. 中国组织化学与细胞化学杂志, 2010, 19(1): 53-57.
|
[20]
|
贺媛琪. 大黄素甲醚-8-O-β-葡萄糖苷(PG)诱导宫颈癌细胞凋亡机制的研究[D]: [博士学位论文]. 济南: 山东大学, 2017.
|
[21]
|
Munagala, R., Aqil, F., Jeyabalan, J. and Gupta, R.C. (2015) Tanshinone IIA Inhibits Viral Oncogene Expression Leading to Apoptosis and In-hibition of Cervical Cancer. Cancer Letters, 356, 536-546.
https://doi.org/10.1016/j.canlet.2014.09.037
|
[22]
|
Li, M.C., Wang, G., Zhang, R.W., Duan, S.Q. and Chen, J.Y. (2019) Tanshinone IIA Inhibits Proliferation and Activates Apoptosis in C4-1 Cervical Carcinoma Cells in vitro. Bio-technology & Biotechnological Equipment, 33, 1599-1607. https://doi.org/10.1080/13102818.2019.1677175
|
[23]
|
黄颖, 史耀琪, 胡佳明, 等. 姜黄素调控LncRNA MEG3/miR-21/PTEN通路促HPV阳性宫颈癌细胞凋亡[J]. 温州医科大学学报, 2022, 52(2): 115-120.
|
[24]
|
Vinaykumar, N. and Maruti, P.J. (2020) Clinical Profile of Acute Lower Respiratory Tract Infections in Children Aged 2-60 Months: An Observational Study. Journal of Family Medicine and Primary Care, 9, 5152-5157.
https://doi.org/10.4103/jfmpc.jfmpc_624_20
|
[25]
|
李文娟, 陈艳华, 王娜, 等. 姜黄素对宫颈癌细胞系中c-Jun及JAK-STAT信号传导通路的影响机制研究[J]. 广西医科大学学报, 2020, 37(2): 213-218.
|
[26]
|
郭锡春, 陈景华, 高如俊, 等. 姜黄素通过miR-29b/KDM2A介导PI3K/AKT信号通路抑制宫颈癌细胞的侵袭和迁移[J]. 中国药学(英文版), 2020, 29(6): 398-410.
|
[27]
|
Fife, K.H., Wu, J.W., Squires, K.E., et al. (2009) Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, 51, 274-282. https://doi.org/10.1097/QAI.0b013e3181a97be5
|
[28]
|
Krajewski, C. and Sucato, G. (2014) Reproductive Health Care after Transplantation. Best Practice & Research Clinical Obstetrics & Gynaecology, 28, 1222-1234. https://doi.org/10.1016/j.bpobgyn.2014.09.002
|
[29]
|
李锋, 熊丽丽, 田晓予, 等. 高危型HPV感染的宫颈癌和癌前病变中Th1/Th2漂移情况研究[J]. 河南科技大学学报(医学版), 2007, 25(2): 88-89.
|
[30]
|
蒋婴, 张蔚苓. 高危型HPV感染患者Th1/Th2平衡与中医体质相关性研究[J]. 浙江中医药大学学报, 2019, 43(7): 669-672.
|
[31]
|
姚冬梅, 濮德敏. 二黄散对高危型HPV感染CINⅠ和CINⅡ患者Th1/Th2表达的影响[J]. 医药导报, 2013, 32(4): 488-490.
|
[32]
|
张明哲, 叶贵丹. 止带方加减治疗慢性宫颈炎合并HPV感染LEEP术后观察[J]. 中国实验方剂学杂志, 2017, 23(17): 211-216.
|
[33]
|
徐香杰, 谌向君, 田宾. 疏肝健脾抑瘤汤对宫颈高危型人乳头瘤病毒感染的治疗效果及对Th1/Th2不均衡表达的影响[J]. 四川中医, 2020, 38(4): 180-183.
|
[34]
|
张瑜, 张宜群, 赵珊琼. 中药外治法对宫颈HR-HPV感染细胞因子水平的影响[J]. 现代实用医学, 2020, 32(7): 828-830.
|
[35]
|
Li, L., Jiang, W., Zeng, S.Y., et al. (2014) Prospective Study of hTERC Gene Detection by Fluorescence in situ Hybridization (FISH) in Cervical Intraepithelial Neoplasia 1 Natural Prognosis. European Journal of Gynaecological Oncology, 35, 289-291.
|
[36]
|
赵红珂, 莫凌昭. 慢病毒介导的siRNA沉默hTERT基因对宫颈癌Caski细胞增殖和凋亡的影响[J]. 广西医学, 2015(5): 599-602.
|
[37]
|
韩玉平, 徐卓, 张凡, 等. 白花蛇舌草对宫颈癌细胞增殖、端粒酶活性及Ki-67基因表达的影响[J]. 现代中西医结合杂志, 2019, 28(35): 3914-3918.
|
[38]
|
肖静, 吴佳, 于斌, 等. 疣毒净制剂治疗宫颈HR-HPV感染患者的疗效观察[J]. 中国中西医结合杂志, 2012, 32(9): 1212-1215.
|
[39]
|
Chase, D., Goulder, A., Zenhausern, F., Monk, B. and Herbst-Kralovetz, M. (2015) The Vaginal and Gastrointestinal Microbiomes in Gyneco-logic Cancers: A Review of Applications in Etiology, Symptoms and Treatment. Gynecologic Oncology, 1389, 190-200. https://doi.org/10.1016/j.ygyno.2015.04.036
|
[40]
|
刘静, 格日丽, 陈丽媛, 等. 宫颈人乳头瘤病毒感染与阴道微生态环境的关系[J]. 新疆医学, 2021, 51(10): 1118-1120.
|
[41]
|
韦彩素, 陈慧峰, 李建湘, 等. 子宫颈病变患者阴道微生态环境与HR-HPV感染的相关性及子宫颈病变的影响因素分析[J]. 中外医学研究, 2021, 19(17): 4-7.
|
[42]
|
孟瑶. 人乳头瘤状病毒感染与阴道微环境的关系及中药干预研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2018.
|
[43]
|
潘婷. 完带汤对脾虚证高危型HPV感染者疗效及阴道微生态的影响[D]: [硕士学位论文]. 长沙: 湖南中医药大学, 2021.
|
[44]
|
钱雪佳. 534例HR-HPV感染患者中医证型、阴道微生态分布及宫颈病变的相关危险因素研究[D]: [硕士学位论文]. 天津: 天津中医药大学, 2020.
|
[45]
|
叶银利, 桑晓庆, 熊翡, 等. 宫颈HPV感染患者的体质与中医证型分析[J]. 浙江中医杂志, 2016, 51(3): 168-169.
|
[46]
|
(清)傅山. 傅青主女科[M]. 上海: 上海人民出版社, 1978: 1.
|
[47]
|
曹珊, 张艺嘉, 樊珂. 崔应民治疗持续性HPV感染临床经验撷英[J]. 时珍国医国药, 2021, 32(4): 981-984.
|
[48]
|
张国华, 王轶蓉, 王秀云. 王秀云教授治疗HPV持续性感染经验撷菁[J]. 辽宁中医药大学学报, 2021, 23(6): 16-19.
|
[49]
|
孟瑶, 马越, 孙先航, 等. 李大可治疗HPV感染临床经验[J]. 辽宁中医杂志, 2018, 45(6): 1164-1166.
|
[50]
|
蒋贵林, 安晓青, 余文婷, 等. 化湿解毒止带方治疗慢性宫颈炎伴HPV感染的临床疗效及对血清hs-CRP、TNF-α水平的影响[J]. 中华中医药学刊, 2020, 38(11): 14-17.
|
[51]
|
曹丹丹. 加味二妙方治疗HR-HPV持续感染合并CINI的临床观察及对宫颈TLR4、NF-κB表达的影响[D]: [硕士学位论文]. 南京: 南京中医药大学, 2018.
|
[52]
|
范冬青. 益气化湿解毒汤联合综合干预对慢性宫颈炎合并HPV感染的影响[J]. 光明中医, 2022, 37(15): 2688-2690.
|
[53]
|
吕娜, 张可心, 匡红影, 等. 健脾利湿解毒汤治疗宫颈HR-HPV感染(脾虚湿盛型)临床疗效及对阴道微环境的影响[J]. 辽宁中医杂志, 2022, 49(4): 72-75.
|
[54]
|
范建灵, 余军. 扶正解毒方治疗高危型HPV感染伴Ⅰ级宫颈上皮内瘤变疗效观察[J]. 现代中西医结合杂志, 2021, 30(23): 2592-2595.
|
[55]
|
陈翊, 夏爱军, 周琴, 等. 扶正清毒法干预宫颈高危型HPV感染转归的临床研究[J]. 中医药导报, 2018, 24(21): 53-56.
|
[56]
|
卢岩, 段晓敏, 孙利华. 保妇康栓和辛复宁治疗HPV感染的成本-效果分析[J]. 中国循证医学杂志, 2017, 17(6): 711-718.
|
[57]
|
苏小玉, 蒙莉萍, 邹聪聪, 等. 重组人干扰素凝胶联合保妇康栓治疗宫颈高危型HPV感染的临床观察[J]. 中国药房, 2020, 31(8): 984-988.
|
[58]
|
陈顺泰, 花宝金. 中医药防治宫颈癌人乳头瘤病毒感染的研究进展[J]. 吉林中医药, 2020, 40(2): 275-277.
|
[59]
|
吴思依. 针灸治疗宫颈HR-HPV感染的临床疗效观察及对宫颈局部免疫环境影响的研究[D]: [硕士学位论文]. 天津: 天津中医药大学, 2022.
|
[60]
|
杜菲菲, 李灵芝. 温针灸治疗低级别宫颈上皮内瘤变的疗效观察[J]. 内蒙古中医药, 2022, 41(4): 110-112.
|
[61]
|
王楠. 埋线联合参芪苓苡汤治疗高危型HPV持续感染的临床疗效观察[D]: [硕士学位论文]. 晋中: 山西中医药大学, 2021.
|
[62]
|
盛温温, 杜志斌. 止带方联合三黄散治疗HR-HPV感染临床研究[J]. 实用中医药杂志, 2021, 37(9): 1461-1463.
|